Stay updated with breaking news from Bob Mayberry. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Associate professor of English, playwright and theater director Bob Mayberry will make thespians think during his “Who Wrote Shakespeare?” presentation at Ojai Library, 111 E. Ojai Ave., on Wednesday, May
Date Time Neoadjuvant combination immunotherapy improves outcomes for early stage non-small cell lung cancer The first randomized Phase II clinical trial to report on single and combined neoadjuvant immune checkpoint inhibitor therapy in stage I-III non-small cell lung cancer (NSCLC) found combination therapy produced a significant clinical benefit, as assessed by major pathologic response (MPR) rate, as well as enhanced tumor immune cell infiltration and immunological memory. Researchers from The University of Texas MD Anderson Cancer Center published the study results today in Nature Medici...